AMRN News and Press, Amarin Corporation plc From 10/29/25

2025-10-29 07:07:43 ET More on Amarin Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom Amarin Q3 2025 Earnings Preview Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Am...

2025-10-28 10:23:45 ET More on Amarin Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript Amarin targets $70M cost savings and accelerates VAZKEPA European expansion through Recordati p...

DUBLIN and BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the following statement in response to the recent action taken by the U.S. Food and Drug Administration...

2025-10-26 08:00:03 ET Earnings season hits full stride in the last week of October, with a broad cross-sector lineup spanning tech, energy, financials, healthcare, consumer goods, and crypto-linked names.... Read the full article on Seeking Alpha For further details see: Ea...

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report third quarter 2025 financial results and conduct a conference call on Wednesday,...

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a pharmaceutical company focusing on addressing unmet n...

2025-09-29 17:52:51 ET ... Read the full article on Seeking Alpha For further details see: Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom

2025-09-03 09:19:11 ET More on Ionis Pharmaceuticals Positive CORE and CORE2 Topline Results Ionis Pharmaceuticals, Inc. (IONS) Positive CORE And CORE2 Topline Results (Transcript) Ionis: Dawnzera Approval Kicks Off New Era For Strikingly Undervalued Pharma I...

DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted in vitro data assessing the effects of EPA on lipoprotein(a) [Lp(a)] oxidation and on cellular stress and inflammatory protein expression in endothelial cells and pr...

-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today...